RLAY
Price
$2.00
Change
-$0.29 (-12.66%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
389.05M
26 days until earnings call
RXRX
Price
$4.24
Change
-$0.57 (-11.85%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
1.93B
32 days until earnings call
Ad is loading...

RLAY vs RXRX

Header iconRLAY vs RXRX Comparison
Open Charts RLAY vs RXRXBanner chart's image
Relay Therapeutics
Price$2.00
Change-$0.29 (-12.66%)
Volume$67.43K
Capitalization389.05M
Recursion Pharmaceuticals
Price$4.24
Change-$0.57 (-11.85%)
Volume$208.06K
Capitalization1.93B
RLAY vs RXRX Comparison Chart
Loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLAY vs. RXRX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Hold and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (RLAY: $2.29 vs. RXRX: $4.81)
Brand notoriety: RLAY and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 134% vs. RXRX: 74%
Market capitalization -- RLAY: $389.05M vs. RXRX: $1.93B
RLAY [@Biotechnology] is valued at $389.05M. RXRX’s [@Biotechnology] market capitalization is $1.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RLAY is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than RXRX.

Price Growth

RLAY (@Biotechnology) experienced а -23.41% price change this week, while RXRX (@Biotechnology) price change was -19.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

RLAY is expected to report earnings on May 01, 2025.

RXRX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.93B) has a higher market cap than RLAY($389M). RXRX YTD gains are higher at: -28.846 vs. RLAY (-44.417). RLAY has higher annual earnings (EBITDA): -380.21M vs. RXRX (-426.72M). RLAY has more cash in the bank: 781M vs. RXRX (594M). RLAY has less debt than RXRX: RLAY (48.5M) vs RXRX (108M). RXRX has higher revenues than RLAY: RXRX (58.5M) vs RLAY (10M).
RLAYRXRXRLAY / RXRX
Capitalization389M1.93B20%
EBITDA-380.21M-426.72M89%
Gain YTD-44.417-28.846154%
P/E RatioN/AN/A-
Revenue10M58.5M17%
Total Cash781M594M131%
Total Debt48.5M108M45%
TECHNICAL ANALYSIS
Technical Analysis
RLAYRXRX
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
83%
Momentum
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
86%
MACD
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
86%
Advances
ODDS (%)
Bullish Trend 25 days ago
80%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
80%
Aroon
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
87%
View a ticker or compare two or three
Ad is loading...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-8.03%
XNCR - RLAY
46%
Loosely correlated
-9.16%
BCYC - RLAY
44%
Loosely correlated
-7.70%
FHTX - RLAY
43%
Loosely correlated
-7.89%
RXRX - RLAY
42%
Loosely correlated
-9.07%
BDTX - RLAY
42%
Loosely correlated
-4.43%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-9.07%
CRSP - RXRX
69%
Closely correlated
-4.47%
BEAM - RXRX
62%
Loosely correlated
-10.93%
NTLA - RXRX
58%
Loosely correlated
-5.62%
PRME - RXRX
56%
Loosely correlated
-10.06%
ABSI - RXRX
53%
Loosely correlated
-9.88%
More